| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,738 |
18,471 |
$993K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,928 |
7,827 |
$598K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,330 |
6,221 |
$466K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,981 |
12,259 |
$465K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
34,790 |
15,077 |
$365K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,206 |
4,171 |
$341K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,651 |
1,638 |
$145K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,653 |
9,402 |
$95K |
| 92552 |
|
5,668 |
5,074 |
$92K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,428 |
8,399 |
$86K |
| 99429 |
|
2,074 |
1,923 |
$61K |
| 99381 |
|
664 |
656 |
$46K |
| 90461 |
|
6,360 |
5,574 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,405 |
1,375 |
$33K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,097 |
1,075 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,293 |
1,125 |
$23K |
| 99383 |
|
96 |
94 |
$8K |
| 83655 |
|
797 |
776 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
288 |
286 |
$4K |
| 96160 |
|
2,010 |
1,978 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
248 |
248 |
$3K |
| 87807 |
|
333 |
331 |
$3K |
| 99382 |
|
25 |
24 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
157 |
154 |
$2K |
| 99384 |
|
18 |
18 |
$2K |
| 99460 |
|
26 |
25 |
$2K |
| 85018 |
|
1,624 |
1,598 |
$1K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
31 |
26 |
$1K |
| 90671 |
|
2,243 |
2,228 |
$1K |
| 0071A |
|
20 |
20 |
$800.00 |
| 90473 |
|
59 |
58 |
$755.05 |
| 99462 |
|
31 |
24 |
$604.60 |
| 96161 |
|
466 |
443 |
$486.08 |
| 0072A |
|
12 |
12 |
$480.00 |
| 81002 |
|
216 |
210 |
$445.75 |
| 99050 |
|
16 |
15 |
$239.36 |
| 94761 |
|
25 |
25 |
$58.69 |
| 99173 |
|
5,640 |
5,372 |
$34.20 |
| 90633 |
|
2,684 |
2,637 |
$16.54 |
| 94664 |
|
12 |
12 |
$16.24 |
| 90619 |
|
146 |
143 |
$3.79 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
56 |
54 |
$2.11 |
| 90686 |
|
3,417 |
3,372 |
$0.04 |
| 90698 |
|
3,938 |
3,890 |
$0.00 |
| 90744 |
|
2,604 |
2,577 |
$0.00 |
| 91307 |
|
59 |
57 |
$0.00 |
| 36416 |
|
985 |
977 |
$0.00 |
| 90680 |
|
3,280 |
3,236 |
$0.00 |
| 90696 |
|
282 |
279 |
$0.00 |
| 90651 |
|
352 |
346 |
$0.00 |
| 90716 |
|
200 |
198 |
$0.00 |
| 90660 |
|
112 |
112 |
$0.00 |
| 90656 |
|
34 |
34 |
$0.00 |
| 90688 |
|
53 |
51 |
$0.00 |
| 90648 |
|
553 |
541 |
$0.00 |
| 90700 |
|
784 |
774 |
$0.00 |
| 90710 |
|
1,164 |
1,149 |
$0.00 |
| 90670 |
|
3,138 |
3,085 |
$0.00 |
| 90672 |
|
588 |
576 |
$0.00 |
| 90707 |
|
177 |
171 |
$0.00 |
| 90734 |
|
170 |
165 |
$0.00 |
| 90715 |
|
101 |
99 |
$0.00 |